CoChat

The DOI matches its Crossref record; 56 of the 58 references it cites were found in a registry or an index.

Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials

Casula, Manuela, Soranna, Davide, Catapano, Alberico L., Corrao, Giovanni · 2013 · Atherosclerosis Supplements

Abstract

Background Although omega-3 fatty acids have well documented properties which would reduce the cardiovascular (CV) disease risk, the evidence from randomized controlled trials (RCTs) remains inconclusive. We performed a meta-analysis of the available RCTs for investigating the CV preventive effect of administrating at least 1 gram/day, and for at least 1 year, omega-3 fatty acid supplements to patients with existing CV disease.Methods RCTs published up to March 2013 were searched from PubMed, EMBASE, and the Cochrane Library. Two of us independently reviewed and selected eligible trials.Results Of 360 articles retrieved, 11 randomized, double-blind, placebo controlled trials fulfilling inclusion criteria, overall involving 15,348 patients with a history of CV disease, were considered in the final analyses. No statistically significant association was observed for all-cause mortality (RR, 0.89; 95% CI, 0.78 to 1.02) and stroke (RR, 1.31; 95% CI, 0.90 to 1.90). Conversely, statistically significant protective effects were observed for cardiac death (RR, 0.68; 95% CI, 0.56 to 0.83), sudden death (RR, 0.67; 95% CI, 0.52 to 0.87), and myocardial infarction (RR, 0.75; 95% CI, 0.63 to 0.88).Conclusion Overall, our results supply evidence that long-term effect of high dose omega-3 fatty acid supplementation may be beneficial for the onset of cardiac death, sudden death and myocardial infarction among patients with a history of cardiovascular disease.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1567-5688(13)70005-9

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 58 references

Cited by

See all 152

Metadata

Authors
Casula, M., Soranna, D., Catapano, A. L., & Corrao, G.
Affiliations
  • University of Milan (IT)
  • University of Milano-Bicocca (IT)
Corresponding author
  • Casula, Manuela
  • Corrao, Giovanni
Venue
Atherosclerosis Supplements
Publisher
Elsevier BV
Published
2013-08
Volume
14
Issue
2
Pages
243-251
ISSN
1567-5688 (ISSN-L)
OpenAlex
W2073981737
Cited by
152
References
58
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 9 · 2022: 11 · 2021: 10 · 2020: 11 · 2019: 8 · 2018: 20 · 2017: 21 · 2016: 18 · 2015: 18 · 2014: 15 · 2013: 1
FWCI
1.95
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Atherosclerosis Supplements (publishedVersion)
  • PubMed (publishedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
omega-3 fatty acids, high-dose supplementation, secondary prevention, cardiovascular disease, cardiovascular mortality, sudden death, myocardial infarction, stroke, all-cause mortality
MeSH terms
Cardiovascular Diseases, Double-Blind Method, Humans, Risk Factors, Fatty Acids, Omega-3, Odds Ratio, Randomized Controlled Trials as Topic, Treatment Outcome, Disease Progression, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials. https://app.cochat.ai/papers/10.1016/s1567-5688(13)70005-9
The paper
Casula, M., Soranna, D., Catapano, A. L., & Corrao, G. (2013). Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, double blind, placebo controlled trials. Atherosclerosis Supplements. https://doi.org/10.1016/s1567-5688(13)70005-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.